Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

洪榮志 (Jung-Jyh Hung)

洪榮志(Jung-Jyh Hung)圖 Appointment

[Profile]

  • Education
    • M.D. of National Yang-Ming University ,
    • Ph.D. of Institute of Clinical Medicine of National Yang-Ming University,
  • Career and Experience
    Current Positions：
    • - Now, Professor of Surgery, Faculty of Medicine, National Yang-Ming University,
    • - Now, Attending Surgeon, Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital,
    Experiences：
    • - , Resident training in thoracic surgery in Taipei Veterans General Hospital ,
    • - , Attending Surgeon in Taipei Veterans General Hospital ,
    • - , Attending Surgeon in Cathay General Hospital,
  • Medical Expertise
    1. Minimally invasive thoracoscopic surgery (lung cancer, esophageal cancer, mediastinal disease, pneumothorax, empyema, me
  • License
    License of surgeon, Taiwan License of thoracic surgeon, Taiwan License of physician in lung cancer, Taiwan License of physician in critical care medicine, Taiwan

[Publications]

 台灣消化系外科醫學會2007年最佳學術海報獎

台灣胸腔及心臟血管外科學會2008年新秀論文獎

台灣胸腔及心臟血管外科學會2009年理事長論文獎

台灣胸腔及心臟血管外科學會2010年理事長論文獎

台灣胸腔暨重症加護醫學會2013優秀原著論文獎  Young Investigator Award

台灣胸腔暨重症加護醫學會2014優秀原著論文獎  Young Investigator Award

11th International Conference of the Asian Clinical Oncology Society (ACOS) Merit   

Award (2014)

中央研究院2016年輕學者研究著作獎

台灣胸腔及心臟血管外科學會2018年理事長論文獎

第24屆台灣癌症聯合學術年會2019優秀論文獎『基轉組』第一名

台灣胸腔及心臟血管外科學會2019年理事長論文獎

  1. Hung JJ,* Kao YS, Huang CH, et al. Overexpression of Aiolos promotes epithelial-mesenchymal transition and cancer stem cell-like properties in lung cancer cells. Sci Rep 2019;9:2991. (SCI, IF: 3.998) (*Corresponding author)
  2. Lin YH, Hung JJ,* Yeh YC, et al. Prognostic significance of basal versus superior segment in patients with completely resected lung adenocarcinoma in the lower lobe. Thorac Cancer 2019;10:312-320. (SCI, IF: 2.610) (*Corresponding author)
  3. Hung JJ,* Yeh YC, Hsu WH. Prognostic significance of aldo-keto reductase family 1 member B10 in patients with resected lung adenocarcinoma. Thorac Cancer 2018;9:1492-1499. (SCI, IF: 2.610) (*Corresponding author)
  4. Hung JJ,* Yeh YC, Wu YC, et al. Prognostic Factors in Completely Resected Node-negative Lung Adenocarcinoma of 3cm or Smaller. J Thorac Oncol 2017;12:1824-1833. (SCI, IF: 13.357) (*Corresponding author)
  5. Hung JJ, Wu YC, Chou TY, et al. Adjuvant Chemotherapy Improves the Probability of Freedom from Recurrence in Patients with Resected Stage IB Lung Adenocarcinoma. Ann Thorac Surg 2016;101:1346-1353. (SCI, IF: 3.639)
  6. Hung JJ,* Yeh YC, Jeng WJ, et al. Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3cm or smaller. Eur J Cardiothorac Surg 2016;50:329-336. (SCI, IF 3.486) (*Corresponding author)
  7. Hung JJ,* Yeh YC, Jeng WJ, et al. Prognostic Factors of Survival after Recurrence in Patients with Resected Lung Adenocarcinoma. J Thorac Oncol 2015;10:1328-1336. (SCI, IF: 13.357) (*Corresponding author)
  8. Hung JJ, Yeh YC, Jeng WJ, et al. Predictive Value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Tumor Recurrence and Patient Survival. J Clin Oncol 2014;32:2357-2364. (SCI, IF: 32.956)
  9. Hung JJ,* Jeng WJ, Chou TY, et al. Prognostic Value of the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification on Death and Recurrence in Completely Resected Stage I Lung Adenocarcinoma. Ann Surg 2013;258:1079-86. (SCI, IF: 10.130) (*Corresponding author)
  10. Liu CY, Hung JJ,* Wang BY, et al. Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer. Eur Respir J 2013;41:649-55. (SCI, IF: 12.339) (*Co-first author)
  11. Hung JJ,* Jeng WJ, Hsu WH, et al. Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer. Chest 2012;142:141-50. (SCI, IF: 8.308) (*Corresponding author)
  12. Hung JJ,* Jeng WJ, Hsu WH, et al. Time Trends of Overall Survival and Survival after Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer. J Thorac Oncol 2012;7:397-405. (SCI, IF: 13.357) (*Corresponding author)
  13. Hung JJ, Jeng WJ, Hsu WH, et al. Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non-Small-Cell Lung Cancer. J Thorac Oncol 2012;7:1115-23. (SCI, IF: 13.357)
  14. Hung JJ,* Jeng WJ, Hsu WH, et al. Prognostic factors of post-recurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax 2010;65:241-5. (SCI, IF: 8.834) (*Corresponding author)
  15. Hung JJ, Jeng WJ, Hsu WH, et al. Prognostic factors in pathological stage IB non-small cell lung cancer greater than 3 cm. Eur Respir J 2010;36:1355-61. (SCI, IF: 12.339)
  16. Hung JJ, Hsu WH, Hsieh CC, et al. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 2009;64:192-6. (SCI, IF: 8.834)
  17. Hung JJ, Yang MH, Hsu HS, et al. Prognostic significance of hypoxia-inducible factor-1a, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax 2009;64:1082-9. (SCI, IF: 8.834)
  18. Hung JJ, Wang CY, Huang MH, et al. Prognostic Factors in Resected Stage I Non-small Cell Lung Cancer of Diameter 3 cm or Less: Visceral pleural invasion did not influence overall and disease-free survival. J Thorac Cardiovasc Surg 2007;134:638-43. (SCI, IF: 4.451)
回到最上